Saturday, June 13, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1049 of 1,261
  1. US 7439045

    pH controlled fermentation process for pseudomonic acid production

    TEVA Gyógyszergyár Zártkörüen Müködö Részvénytárasaság · Granted Oct 21, 2008 · Expires Oct 16, 2028

    granted
  2. US 7439013

    Biocompatible polymer and filter for selectively eliminating leucocytes using the same

    ASAHI KASEI KURARAY MEDICAL CO., LTD. · Granted Oct 21, 2008 · Expires Oct 16, 2028

    granted
  3. US 2008255015

    COMPOSITION BASED ON GLYCEROL ETHER/POLYOL MIXTURES

    AIR LIQUIDE SANTE INT [FR] · Granted Oct 16, 2008 · Expires Oct 11, 2028

    granted
  4. US 7435742

    Quinuclidine derivatives and pharmaceutical compositions containing the same

    Laboratories Almirall, S.A. · Granted Oct 14, 2008 · Expires Oct 9, 2028

    granted
  5. US 7435801

    Antibodies and other ligands directed against KIR2DL4 receptor for production of interferon gamma

    The United States of America, as represented by the Department of Health and Human Services · Granted Oct 14, 2008 · Expires Oct 9, 2028

    granted
  6. US 7435814

    2,4-Pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Oct 14, 2008 · Expires Oct 9, 2028

    granted
  7. US 7435741

    2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Oct 14, 2008 · Expires Oct 9, 2028

    granted
  8. US 7435733

    Mineralocorticoid receptor modulator compounds and methods, and pharmaceutical compositions containing these compounds

    Ligand Pharmaceuticals Incorporated · Granted Oct 14, 2008 · Expires Oct 9, 2028

    granted
  9. US 7435755

    CDDO-compounds and combination therapies thereof

    The Board of Regents of the University of Texas System · Granted Oct 14, 2008 · Expires Oct 9, 2028

    granted
  10. US 7432290

    Inhibitors of IMPDH enzyme

    Vertex Pharmaceuticals Incorporated · Granted Oct 7, 2008 · Expires Oct 2, 2028

    granted
  11. US 7432349

    Tumor suppressor gene, p28ING5

    The United States of America, as represented by the Department of Health and Human Services · Granted Oct 7, 2008 · Expires Oct 2, 2028

    granted
  12. US 7432331

    Hydrolytically stable maleimide-terminated polymers

    Nektar Therapeutics AL, Corporation · Granted Oct 7, 2008 · Expires Oct 2, 2028

    granted
  13. US 7432330

    Hydrolytically stable maleimide-terminated polymers

    Nektar Therapeutics AL, Corporation · Granted Oct 7, 2008 · Expires Oct 2, 2028

    granted
  14. US 7432304

    Small molecule antagonists of Bcl-2 family proteins

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Oct 7, 2008 · Expires Oct 2, 2028

    granted
  15. US 7432242

    Inhibitors of RGS proteins

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Oct 7, 2008 · Expires Oct 2, 2028

    granted
  16. US 7432300

    Gossypol co-crystals and the use thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Oct 7, 2008 · Expires Oct 2, 2028

    granted
  17. US 7432292

    Sulfhydantoins as phosphate isosteres

    Vertex Pharmaceuticals Incorporated · Granted Oct 7, 2008 · Expires Oct 2, 2028

    granted
  18. US 7432093

    Soluble, functional apoptotic protease-activating factor 1 fragments

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Oct 7, 2008 · Expires Oct 2, 2028

    granted
  19. US 7432067

    Methods of detection of MATER protein autoantibodies

    The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer · Granted Oct 7, 2008 · Expires Oct 2, 2028

    granted
  20. US 7431932

    Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions

    ONCOLYTICS BIOTECH INC. · Granted Oct 7, 2008 · Expires Oct 2, 2028

    granted
  21. US 7431931

    Compositions and method for preventing reactogenicity associated with administration of immunogenic live rotavirus compositions

    The United States of America, as represented by the Department of Health and Human Services · Granted Oct 7, 2008 · Expires Oct 2, 2028

    granted
  22. US 7432047

    Method for selective inactivation of viral replication

    Rigel Pharmaceuticals, Inc. · Granted Oct 7, 2008 · Expires Oct 2, 2028

    granted
  23. US 7431915

    Peptides whose uptake by cells is controllable

    The Regents of the University of California · Granted Oct 7, 2008 · Expires Oct 2, 2028

    granted
  24. US 7431929

    Use of vaccinia virus deleted for the E3L gene as a vaccine vector

    THE ARIZONA BOARD OF REGENTS · Granted Oct 7, 2008 · Expires Oct 2, 2028

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.